Predicting response to fingolimod in patients with relapsing-remitting multiple sclerosis

被引：0
|
作者：
Giuliani, M. [1 ]
Prosperini, L. [1 ]
Fanelli, F. [1 ]
Hirsch, M. N. [1 ]
De Angelis, F. [1 ,2 ]
Pozzilli, C. [1 ]
机构：
[1] Univ Roma La Sapienza, I-00185 Rome, Italy
[2] UCL, London, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P633
引用
收藏
页码：306 / 306
页数：1
相关论文
共 50 条
  • [21] Predicting cognitive impairment in relapsing-remitting multiple sclerosis
    Summers, M.
    Anderson, V. M.
    Fisniku, L.
    Davies, G. R.
    Rashid, W.
    Cipolotti, L.
    Ron, M. A.
    [J]. JOURNAL OF NEUROLOGY, 2006, 253 : 7 - 7
  • [22] Fingolimod A Review of its Use in the Management of Relapsing-Remitting Multiple Sclerosis
    Scott, Lesley J.
    [J]. CNS DRUGS, 2011, 25 (08) : 673 - 698
  • [23] Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod
    Tully, Timothy
    Barkley, Alastair
    Silber, Eli
    [J]. NEUROLOGY, 2015, 84 (19) : 1999 - 2001
  • [24] Longitudinal Assessment of Retinal Structures in Patients with Relapsing-Remitting Multiple Sclerosis on Fingolimod (Gilenyae®)
    Lin, Jia
    Yarraguntla, Kalyan
    Lichtman-Mikol, Samuel
    Gilroy, Melody
    Bao, Fen
    Santiago-Martinez, Carla
    Seraji-Bozorgzad, Navid
    Bernitsas, Evanthia
    [J]. NEUROLOGY, 2019, 92 (15)
  • [25] Comparative effectiveness of natalizumab and fingolimod in different subgroups of patients with relapsing-remitting multiple sclerosis
    Sharmin, S.
    Lefort, M.
    Andersen, J.
    Horakova, D.
    Havrdova, E. K.
    Alroughani, R.
    Izquierdo, G.
    Eichau, S.
    Ozakbas, S.
    Butzkueven, H.
    Patti, F.
    Onofrj, M.
    Lugaresi, A.
    Terzi, M.
    Grammond, P.
    Grand'Maison, F.
    Yamout, B.
    Prat, A.
    Girard, M.
    Duquette, P.
    Boz, C.
    Trojano, M.
    McCombe, P.
    Slee, M.
    Lechner-Scott, J.
    Turkoglu, R.
    Sola, P.
    Ferraro, D.
    Granella, F.
    Shaygannejad, V.
    Prevost, J.
    Skibina, O.
    Solaro, C.
    Karabudak, R.
    Van Wijmeersch, B.
    Csepany, T.
    Spitaleri, D.
    Vucic, S.
    Leray, E.
    Sorensen, P. S.
    Sellebjerg, F.
    Magyari, M.
    Vukusic, S.
    Kalincik, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 786 - 788
  • [26] Switch to Natalizumab versus Fingolimod in Active Relapsing-Remitting Multiple Sclerosis
    Kalincik, Tomas
    Horakova, Dana
    Spelman, Tim
    Jokubaitis, Vilija
    Trojano, Maria
    Lugaresi, Alessandra
    Izquierdo, Guillermo
    Rozsa, Csilla
    Grammond, Pierre
    Alroughani, Raed
    Duquette, Pierre
    Girard, Marc
    Pucci, Eugenio
    Lechner-Scott, Jeannette
    Slee, Mark
    Fernandez-Bolanos, Ricardo
    Grand'Maison, Francois
    Hupperts, Raymond
    Verheul, Freek
    Hodgkinson, Suzanne
    Oreja-Guevara, Celia
    Spitaleri, Daniele
    Barnett, Michael
    Terzi, Murat
    Bergamaschi, Roberto
    McCombe, Pamela
    Sanchez-Menoyo, Jose
    Simo, Magdolna
    Csepany, Tunde
    Rum, Gabor
    Boz, Cavit
    Havrdova, Eva
    Butzkueven, Helmut
    [J]. ANNALS OF NEUROLOGY, 2015, 77 (03) : 425 - 435
  • [27] Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review
    Ghadiri, Fereshteh
    Mirmosayyeb, Omid
    Sahraian, Mohammad Ali
    Moghadasi, Abdorreza Naser
    Ghajarzadeh, Mahsa
    [J]. CURRENT JOURNAL OF NEUROLOGY, 2023, 22 (02): : 110 - 114
  • [28] Drug holiday therapy of fingolimod in Japanese relapsing-remitting multiple sclerosis
    Ohtani, R.
    Masahiro, M.
    Akiyuki, U.
    Tomohiko, U.
    Hiroki, M.
    Satoshi, K.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 792 - 793
  • [29] The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
    Cavit Boz
    Serkan Ozakbas
    Murat Terzi
    Rana Karabudak
    Serhan Sevim
    Recai Turkoglu
    Aysun Soysal
    Belgin Petek Balcı
    Hüsnü Efendi
    Ömer Faruk Turan
    Nur Yüceyar
    Mehmet Fatih Yetkin
    Serap Zengin Karahan
    Meltem Demirkıran
    Sibel Guler
    Kadriye Agan
    Nefati Kıylıoğlu
    Cavid Baba
    Asli Tuncer
    Mesrure Köseoğlu
    [J]. Neurological Sciences, 2023, 44 : 2121 - 2129
  • [30] Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients
    De Stefano, Nicola
    Tomic, Davorka
    Radue, Ernst-Wilhelm
    Sprenger, Till
    Meier, Daniela Piani
    Haring, Dieter
    Sormani, Maria Pia
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 7 : 98 - 101
12345